Tag : Business Insight

Clinical Research, Pharma & Healthcare Financing

D3 Bio Gets FDA Clearance for Two IND Trials in KRAS Cancers

PR Newswire
by PR Newswire022
D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared...
Healthcare Infrastructure, Operations & Supply Chain

H.I.G. Realty, Barts NHS Launch First Life Sciences Project

PR Newswire
by PR Newswire030
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce a strategic partnership with the...
Legal & Regulatory Services

DXC Welcomes Court Decision Affirming Trade Secrets Award

PR Newswire
by PR Newswire029
Ruling reinforces DXC’s commitment to responsible innovation, ethical conduct, and the protection of intellectual property DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner,...
Human Resources & Talent Development

Amrop Expands Executive Search in Baltics with New Lithuania Office

PR Newswire
by PR Newswire024
Amrop, the global leadership advisory and executive search partnership, today announced a new operational set-up and management structure in Lithuania, strengthening its presence and service...
Healthcare Quality, Patient Safety & Policy

Smartee Denti Reports 100,000 Mandibular Repositioning Cases

PR Newswire
by PR Newswire027
Smartee Denti-Technology today released its 2025 annual review, detailing a pivotal year characterized by the worldwide clinical application of its proprietary mandibular repositioning technology, the inauguration...
Financial Advisory & Services

Cartus Achieves SBTi-Validated Net-Zero Targets Globally

PR Newswire
by PR Newswire023
Corporate Relocation Leader Champions Climate-Conscious Moves for Global Businesses Cartus Corporation, a leader in global talent mobility, today announced that its near-term and net-zero greenhouse...
Public Health, Disease Prevention & Wellness

WuXi AppTec Earns Double “A” Rating for Climate & Water Leadership

PR Newswire
by PR Newswire034
WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the “A List” for...
Consulting & Advisory Services

NOBLE Launches NOBLE IQ to Boost National Security Readiness

PR Newswire
by PR Newswire029
Tom Noble, CEO of Noble Supply and Logistics, LLC, today announced the launch of NOBLE IQ™, a new division delivering integrated safety, security, and operational readiness solutions...
Marketing, Advertising & Branding

Inter Miami CF, Lowe’s Renew Partnership at Miami Freedom Park

PR Newswire
by PR Newswire028
Enhanced partnership expands Lowe’s presence, supporting the construction of Miami Freedom Park, player development, fan experience, and community programs Inter Miami CF today announced the renewal...
Digital Health, Technology & Innovation

Lightera Develops Fiber Temperature Feedback for Safer Laser Use

PR Newswire
by PR Newswire033
BiOS – Hall D Booth #8430, Photonics West Hall F Booth #4505 — Lightera, a global leader in advanced specialty optical fiber solutions, announced today a new development...
Clinical Research, Pharma & Healthcare Financing

Syremis Therapeutics Raises $165M for Mental Health Drugs

Business Wire
by Business Wire056
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
Healthcare Infrastructure, Operations & Supply Chain

AtomVie Secures Supply Deal with Ionetix for Ac-225 Drugs

PR Newswire
by PR Newswire038
AtomVie Global Radiopharma (AtomVie), a global radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing and clinical supply, is pleased to announce a...
Clinical Research, Pharma & Healthcare Financing

PharmAla Biotech Contracts UK CDMO for ALA-002 Production

GlobeNewswire
by GlobeNewswire048
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class...